Trial Profile
A Double Blind, Randomized, Crossover Study to Assess EEG Platform Standardization in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs MK 3134 (Primary) ; Lorazepam
- Indications Dementia
- Focus Adverse reactions
- Sponsors Merck Sharp & Dohme
- 04 Dec 2014 New trial record